PolyPid Ltd
NASDAQ:PYPD

Watchlist Manager
PolyPid Ltd Logo
PolyPid Ltd
NASDAQ:PYPD
Watchlist
Price: 3.5 USD 3.24% Market Closed
Market Cap: 35.7m USD

PolyPid Ltd
Investor Relations

PolyPid Ltd. is a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes. The firm focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

Show more
Loading
PYPD
S&P 500
1Y 3Y 5Y 10Y 15Y 20Y

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Ms. Dikla Czaczkes Akselbrad
CEO & Director
No Bio Available
Mr. Jonny Missulawin
Chief Financial Officer
No Bio Available
Ms. Dalit Hazan
Deputy CEO and Executive VP of R&D, Clinical & Regulatory Affairs
No Bio Available
Mr. Ori Warshavsky
Chief Operating Officer - US
No Bio Available
Ms. Maria Rubin
Vice President of Operations
No Bio Available
Mr. Tal Vilnai
General Counsel & Corporate Secretary
No Bio Available
Ms. Rivi Lev-ari
Vice President of Human Resource
No Bio Available
Dr. Jean-Marc Hagai Pharm.D.
Chief Commercial Officer
No Bio Available

Contacts

Address
Petah Tikva
18 Hasivim Street
Contacts
+972747195700.0
www.polypid.com
sparklesyt

See Also

Summary
PYPD intrinsic value, competitors valuation, and company profile.
DCF Valuation
PYPD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PYPD stock valuation using valuation multiples.
Wall Street Estimates
PYPD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PYPD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 268,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.